Reproducibility of tumor response evaluation in patients with high-grade malignant non-Hodgkin's lymphoma

Medical Oncology

Volumn 18, Issue 2, 2001, Pages 137-140

  Osby E ^a   Taube, A ^a   Cavallin Stahl E ^a   Hagberg, H ^a   Bjorkholm M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Non Hodgkin's lymphoma; Reproducibility; Response evaluation; Review committee

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STATISTICAL ANALYSIS;

ADULT; ENDPOINT DETERMINATION; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; OBSERVER VARIATION; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034810520     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:18:2:137     Document Type: Article

References (14)

1. Reporting outcomes in Hodgkin's disease and lymphoma
2. Reporting results of cancer treatment
3. Toxicity and response criteria of the Eastern Cooperative Oncology Group
4. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
5. Response rate accuracy in oncology trials: Reasons for interobserver variability
6. Updated Kiel classification for lymphomas
7. Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma
8. Randomized trial of r-metHu granulocyte colony-stimulating factor (G-CSF) as adjunct to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin's lymphoma
9. Report of committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
10. The effect of measuring error on the results of therapeutic trials in advanced cancer
11. Analysis of interobserver and intraobserver variability in CT tumor measurements
12. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines
13. Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography